Fund profile · Compiled from public sources

UCB Ventures

Brussels, Belgium · Seed → Series A

Their stated focus (public profile)

UCB Ventures is an evergreen strategic corporate venture fund established in 2017 to invest in early-stage companies in the US and Europe developing novel therapeutic modalities and platforms addressing novel biology. The fund focuses on next-generation cell and gene therapy, regenerative medicine, cell and tissue homeostasis, RNA modulation, oligo-based therapeutics, and synthetic biology. It targets areas adjacent to or beyond UCB's current therapeutic focus, with a commitment to long-term partnerships with entrepreneurs.

Stages: Seed → Series A

Sectors: Deep tech, Life sciences

Website: ucbventures.com

This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.

Is this your fund? Request a correction or removal.

For founders · Find a fund

Search the funds we have on file

Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.

    Looking to claim your own fund? Start here →